ClinicalTrials.Veeva

Menu

Exoskeleton Variability Optimization

University of Nebraska logo

University of Nebraska

Status

Terminated

Conditions

Peripheral Arterial Disease

Treatments

Other: Endurance Evaluation
Other: Exoskeleton Optimization

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04338815
P20GM109090 (U.S. NIH Grant/Contract)
0376-19-FB

Details and patient eligibility

About

Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. In this study, investigators intend to develop and evaluate HITL optimization methods for exoskeletons and use the information to design and evaluate a portable hip exoskeleton. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD.

Full description

Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD.

This study will test different methods for optimizing exoskeletons. It will consist of an habituation session to the hip exoskeleton, an optimization session to find the optimal actuation settings using an algorithm that converges toward the optimum based on real-time measurements (human-in-the-loop algorithm) and a post-test at the end of optimization session to compare different conditions. The outcomes will be evaluated by surface electromyography, exoskeleton sensors, ground reaction force, walking speed, indirect calorimetry, and motion capture (Vicon).

Enrollment

9 patients

Sex

All

Ages

19 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ability to provide written consent

  • Chronic claudication history

  • Ankle-brachial index < 0.90 at rest

  • Stable blood pressure, lipids, and diabetes for > 6 weeks

  • Ability to walk on a treadmill for multiple five-minute spans

  • Ability to fit in exoskeleton

    • Waist circumference 78 to 92 centimeters (31 to 36 inches)
    • Thigh circumference 48 to 60 centimeters (19 to 24 inches)
    • Minimal thigh length 28 centimeters (11 inches)

Exclusion criteria

  • Resting pain or tissue loss due to peripheral artery disease (PAD, Fontaine stage III and IV)

  • Foot ulceration

  • Acute lower extremity event secondary to thromboembolic disease or acute trauma

  • Walking capacity limited by diseases unrelated to PAD, such as:

    • Neurological disorders
    • Musculoskeletal disorders (arthritis, scoliosis, stroke, spinal injury, etc.)
    • History of ankle instability
    • Knee injury
    • Diagnosed joint laxity
    • Lower limb injury
    • Surgery within the past 12 months
    • Joint replacement
    • Pulmonary disease or breathing disorders
    • Cardiovascular disease
    • Vestibular disorder
  • Acute injury or pain in lower extremity

  • Current illness

  • Inability to follow visual cues due to blindness

  • Inability to follow auditory cues due to deafness

  • Pregnant

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

9 participants in 2 patient groups

Optimal Assistance Pattern
Experimental group
Description:
An optimization algorithm will change the assistance pattern on the hip exoskeleton during walking sessions and the optimal assistance pattern will be determined when gait variability is minimized.
Treatment:
Other: Exoskeleton Optimization
Endurance Effectds
Experimental group
Description:
Endurance of participants using ground reaction force (Bertec treadmill), walking speed (Bertec treadmill), indirect calorimetry (Cosmed), and motion capture (Vicon) will be determined.
Treatment:
Other: Endurance Evaluation

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Philippe Malcolm, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems